| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5584890 | Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) | 2017 | 6 Pages |
Abstract
Diabetic patients with CKD have lower circulating 15-epi-LXA4 levels than non-diabetic CKD patients. Low dose aspirin for 12 months increased 15-epi-LXA4 levels in diabetic patients. Given its anti-inflammatory properties, this increase in 15-epi-LXA4 levels may contribute to the beneficial effects of low dose aspirin.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Marian Goicoechea, Maria Dolores Sanchez-Niño, Alberto Ortiz, Soledad GarcÃa de Vinuesa, Borja Quiroga, Carmen Bernis, Enrique Morales, Gema Fernández-Juarez, Patricia de Sequera, Ursula Verdalles, Eduardo Verde, José Luño,